These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15507589)

  • 1. Acid suppression and pneumonia: a clinical indication for rational prescribing.
    Gregor JC
    JAMA; 2004 Oct; 292(16):2012-3. PubMed ID: 15507589
    [No Abstract]   [Full Text] [Related]  

  • 2. Does treating gastroesophageal reflux cause pneumonia?
    Federico M
    J Pediatr Gastroenterol Nutr; 2005 Mar; 40(3):386-7. PubMed ID: 15735501
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs.
    Laheij RJ; Sturkenboom MC; Hassing RJ; Dieleman J; Stricker BH; Jansen JB
    JAMA; 2004 Oct; 292(16):1955-60. PubMed ID: 15507580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Increased risk of pneumonia through gastric acid reduction. Partial evaluation of the Integrated Primary Care Information Project (IPCIP)].
    Nitschmann S
    Internist (Berl); 2006 Apr; 47(4):441-2; discussion 442. PubMed ID: 16511690
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
    Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
    Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs.
    Eurich DT; Sadowski CA; Simpson SH; Marrie TJ; Majumdar SR
    Am J Med; 2010 Jan; 123(1):47-53. PubMed ID: 20102991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community-acquired pneumonia and use of gastric acid-suppressive drugs.
    Sataloff RT
    JAMA; 2005 Feb; 293(7):795-6; author reply 796. PubMed ID: 15713765
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study.
    Dublin S; Walker RL; Jackson ML; Nelson JC; Weiss NS; Jackson LA
    Pharmacoepidemiol Drug Saf; 2010 Aug; 19(8):792-802. PubMed ID: 20623507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of post-stroke pneumonia with proton pump inhibitors, H2 receptor antagonists and mucoprotective agents: A retrospective nationwide cohort study.
    Song TJ; Kim J
    PLoS One; 2019; 14(5):e0216750. PubMed ID: 31067267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric acid suppressants--too much of a good thing?
    Logan IC; Sumukadas D; Witham MD
    Age Ageing; 2010 Jul; 39(4):410-1. PubMed ID: 20507846
    [No Abstract]   [Full Text] [Related]  

  • 11. Community-acquired pneumonia and acid-suppressive drugs: position statement.
    CAG Clinical Affairs Committee
    Can J Gastroenterol; 2006 Feb; 20(2):119-21, 123-5. PubMed ID: 16482239
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nosocomial pneumonia during stress ulcer prophylaxis? - risk of nosocomial pneumonia is increased during stress ulcer prophylaxis].
    Madisch A
    Dtsch Med Wochenschr; 2013 Nov; 138(47):2398. PubMed ID: 24221973
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis.
    Eom CS; Jeon CY; Lim JW; Cho EG; Park SM; Lee KS
    CMAJ; 2011 Feb; 183(3):310-9. PubMed ID: 21173070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitors: bacterial pneumonia.
    Prescrire Int; 2012 Sep; 21(130):210-2. PubMed ID: 23016253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia.
    Johnstone J; Nerenberg K; Loeb M
    Aliment Pharmacol Ther; 2010 Jun; 31(11):1165-77. PubMed ID: 20222914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bleeding and pneumonia in intensive care unit patients given proton pump inhibitor or histamine-2 receptor antagonist for prevention of stress ulcer: a Meta analysis].
    Zhou JF; Wan XY; Huang W; Han LL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Apr; 22(4):221-5. PubMed ID: 20398466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
    Holtmann G; Layer P; Goebell H
    Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort study.
    Bateman BT; Bykov K; Choudhry NK; Schneeweiss S; Gagne JJ; Polinski JM; Franklin JM; Doherty M; Fischer MA; Rassen JA
    BMJ; 2013 Sep; 347():f5416. PubMed ID: 24052582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of long-term gastric acid suppression therapy on the expression of serum gastrin, chromogranin A, and ghrelin].
    Chang YW
    Korean J Gastroenterol; 2009 Feb; 53(2):126-8. PubMed ID: 19237840
    [No Abstract]   [Full Text] [Related]  

  • 20. Proton pump inhibitors and histamine-2 receptor antagonists in the intensive care setting: focus on therapeutic and adverse events.
    MacLaren R; Kassel LE; Kiser TH; Fish DN
    Expert Opin Drug Saf; 2015 Feb; 14(2):269-80. PubMed ID: 25423448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.